Controlled release azithromycin solid dosages forms
US8124123B2 · kind B2 · utility
8Cited by
3References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2007 |
| Grant date | Feb 28, 2012 |
| Priority date | — |
| Expiry date | Sep 20, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2886
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A solid dosage form for oral administration comprising azithromycin in an amount below that which causes gastrointestinal side effects, which dosage form is a controlled release dosage form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.